• Login
    View Item 
    •   DSpace Home
    • AUS Theses & Dissertations
    • Masters Theses
    • View Item
    •   DSpace Home
    • AUS Theses & Dissertations
    • Masters Theses
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    The Use of Transferrin and Ultrasound in Cancer Treatment

    Thumbnail
    View/ Open
    35.232-2019.14 Nour Majdi AlSawaftah.pdf (6.396Mb)
    35.232-2019.14 Nour Majdi AlSawaftah_Compressed.pdf (4.044Mb)
    Date
    2019-05
    Author
    AlSawaftah, Nour Majdi
    Advisor(s)
    Husseini, Ghaleb
    Type
    Thesis
    Metadata
    Show full item record
    Description
    A Master of Science thesis in Biomedical Engineering by Nour Majdi AlSawaftah entitled, “The Use of Transferrin and Ultrasound in Cancer Treatment”, submitted in May 2019. Thesis advisor is Dr. Ghaleb Husseini. Soft and hard copy available.
    Abstract
    Site-specific drug delivery represents an attractive approach in cancer treatment to reduce the undesirable side-effects of anticancer therapeutics and increase the accumulation of drugs at tumor sites. Surface modification of nanoparticles such as liposomes with targeting moieties specific to the receptors on the surface of tumor cells further improves the selectivity of liposomes, while external triggers such as ultrasound can be used to enhance the release of liposomal contents. In this study, the anticancer activity of PEGylated calcein-loaded liposomes targeted with transferrin (Tf) was evaluated. The sizes of liposomes were measured using dynamic light scattering; control liposomes were found to have an average diameter of 82.70±2.88 nm while transferrin liposomes had an average diameter of 87.54±4.81 nm. The presence of transferrin was established using the bicinchoninic acid (BCA) assay, and the total lipid content was quantified using the Stewart assay. Next, low-frequency ultrasound (LFUS) of 20 kHz at three power densities (7.46, 9.85, and 17.31 mW/cm2) and high-frequency ultrasound (HFUS) at two frequencies (1.07MHz and 3MHz) were used to release the contents of 3 batches of control and transferrin liposomes. For LFUS, the release profiles showed an increase in calcein release with increased power density and that transferrin-conjugated liposomes have a significantly higher release when compared to non-targeted liposomes at all three power densities. In addition, nine drug release kinetics’ models were utilized to model the LFUS release profiles. For both types of liposomes, the best fitting models were Korsmeyer-Peppas, Hixson-Crowell, Weibull and Hopfenberg. With regard to HFUS release; both types of liposomes showed a clear increase in release after each insonation; however, the release at 1.07 MHz was higher than that of 3 MHz even though the power density was higher at 3 MHz. Moreover, the release profile for transferrin liposomes showed a more linear increase with time, and the fraction release values tended to be higher than those obtained for control liposomes for both frequencies. Finally, the results of the in-vitro cell work indicated that Tf-modified liposomes coupled with US were able to enhance the intracellular uptake and cytotoxicity of the entrapped calcein by HeLa cells by around 80.09±30.08% compared to control liposomes.
    DSpace URI
    http://hdl.handle.net/11073/16446
    Collections
    • Masters Theses

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsCollege/DeptArchive ReferenceSeriesThis CollectionBy Issue DateAuthorsTitlesSubjectsCollege/DeptArchive ReferenceSeries

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    DSpace software copyright © 2002-2016  DuraSpace
    Submission Policies | Terms of Use | Takedown Policy | Privacy Policy | About Us | Contact Us | Send Feedback

    Return to AUS
    Theme by 
    Atmire NV